Triptorelin Market: Growth Drivers and Challenges
Growth Drivers
-
Growing Prevalence of HIV
According to the World Health Organization, about 38.4 million people worldwide were living with HIV in 2021. Hence, there has been going numerous trials to check the efficiency of triptorelin in HIV patient. However, even though this treatment is not widely used in HIV patients, owing to the ongoing research & development and huge investment from the pharmaceutical organization for the same, triptorelin treatment is estimated to be used to treat such patients during the forecast timeframe.
- Rise in Prostate Cancer Among Men
The second most frequently diagnosed cancer and the fifth highest cause of cancer death in males globally is considered to be prostate cancer, with a poised 1,414,000 new cancer cases and 375,304 deaths in 2020. The hormone testosterone is required for prostate cancer to develop. The testicles in men produce almost all of the testosterone. Triptorelin inhibits testosterone production in the testicles, lowering testosterone levels and slowing or halting the proliferation of cancer cells.
- Surge in the Number of Women Suffering from Endometriosis
According to the World Health Organization, globally about 10% or 190 million women or girls of reproductive age are affected by endometriosis. It causes life-impacting pain in women during sexual intercourse, periods, bowel moment, and more. Hence, its treatment is necessary. Therefore, the use of triptorelin is growing since it has been proven effective with an acceptable safety profile. Also, since it has positive results on the reproductive part of the women, the problem in becoming could be diagnosed.
Challenges
-
High Price of Triptorelin Drugs - Despite having a huge client base, the triptorelin market has a significant obstacle which includes expensive triptorelin drug manufacturing costs, which are passed down to consumers as high medical costs. The expense of manufacturing a drug is further boosted by the fact that the raw materials are unique to the drug, making it essential that they be of high quality. Additionally, the product availability is hindered to those who could afford it owing to the intricacy of the triptorelin manufacturing process, which involves a variety of biological or chemical procedures.
-
Side Effects of Triptorelin
- Lack of Awareness Among People
Triptorelin Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.4% |
|
Base Year Market Size (2024) |
USD 11.1 billion |
|
Forecast Year Market Size (2037) |
USD 21.99 billion |
|
Regional Scope |
|